Open | - |
Close | - |
Volume / Avg. | 0 / 219.852K |
Day Range | - - - |
52 Wk Range | 0.620 - 3.129 |
Market Cap | $23.811M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 1% |
Days to Cover | 1.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ekso Bionics Holdings (NASDAQ: EKSO) through any online brokerage.
Other companies in Ekso Bionics Holdings’s space includes: Precision Optics Corp (NASDAQ:POCI), ENDRA Life Sciences (NASDAQ:NDRA), LENSAR (NASDAQ:LNSR), Predictive Oncology (NASDAQ:POAI) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Ekso Bionics Holdings (NASDAQ: EKSO) was reported by HC Wainwright & Co. on Tuesday, March 5, 2024. The analyst firm set a price target for 9.25 expecting EKSO to rise to within 12 months (a possible 595.49% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Ekso Bionics Holdings (NASDAQ: EKSO) is $1.33 last updated March 18, 2024 at 7:53 PM EDT.
There are no upcoming dividends for Ekso Bionics Holdings.
Ekso Bionics Holdings’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Ekso Bionics Holdings.
Ekso Bionics Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.